Alopecia Drugs Market Research Report- Global Forecast to 2022

Alopecia Drugs Market Research Report- Global Forecast to 2022

ID: MRFR/Pharma/1825-HCRR | November, 2018 | Region: Global | 84 pages | Half-Cooked Research Reports

Global Alopecia Drugs Market Information, by alopecia type (alopecia areata, alopecia totalis, and alopecia universalis), by product type (tropical, oral and others), by end user (hospitals and clinics, saloons and home care) - Forecast till 2022


Market Synopsis of Global Alopecia Drugs Market:


Market Scenario:


Alopecia is loss of hair due to a variety of factors the most important being genetic. The loss of hair due to Alopecia may be partial and restricted to a part of body or complete loss of hair. The market for alopecia drug treatment represents a huge opportunity as America alone spends ~ $ 3 billion on hair loss treatment. The market is also choked with unethical products having no effect on the progress of the condition. In fact many products do more harm than good.


The primary market drivers are genetics, increasing awareness, modern lifestyle changes, stress, drug-induced alopecia etc. The constraining factors are unethical spurious products, poor efficacy and efficiency of treatment resulting in poor economics to the patient, neglect of alopecia as it is not life threatening and noncontagious etc. The market is also extremely fragmented with numerous players small and big and the lifecycle of products is very low. The market is also very susceptible to social currents and advertisements.


The global market for alopecia drugs is expected to reach around $ 11.8 billion by the end of the forecast period and is expected to grow at a CAGR of ~ 6.92%. 


Study Objectives Global Alopecia Drugs Market:



  • To provide detail analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global alopecia drugs market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by alopecia type, by product type, by gender and by end user.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


Intended Audience



  • Alopecia Drugs Manufacturers

  • Alopecia Drugs Suppliers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories

  • Contract Manufacturing Organizations


Key Players for Global Alopecia Drugs Market:

Some of the key players in this market are: Cipla Inc., Dr. Reddy’s Laboratories Ltd., Johnson & Johnson, Merck & Co., Ranbaxy Laboratories Ltd, The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Sun Pharmaceutical Industries Ltd. and others.


Segments:


Global Alopecia Drugs market has been segmented on the basis of alopecia type which comprises alopecia areata, alopecia totalis, and alopecia universalis. On the basis of product type; which comprises tropical, oral and others. On the basis of end users; market is segmented into hospitals and clinics, saloons and home care.


Regional Analysis of Global Alopecia Drugs Market:


Globally America is the largest market for alopecia drugs. The American market for alopecia drugs is expected to grow by a CAGR of ~ 4% around $ 3.75 billion by the end of the forecast period of 2016-2022.  Europe is the second-largest market for alopecia drugs. Asia pacific region is expected to be fastest growing region in alopecia drugs market.


The report for Global Alopecia Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.


 

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Alopecia Drugs market, Alopecia Type

5.1 Introduction

5.2 Alopecia Areata

5.3 Alopecia Totalis

5.4 Alopecia Universalis

5.5 Others

6 Global Alopecia Drugs Market, By Product Type

6.1 Introduction

6.2 Tropical

6.3 Oral

6.4 Others

7 Global Alopecia Drugs Market, By Gender

7.1 Introduction

7.2 Men

7.3 Women

7.4 Children

8 Global Alopecia Drugs Market, By End-Users

8.1 Introduction

8.2 Hospitals and Clinics

8.3 Saloons

8.4 Home Care

9 Global Alopecia Drugs market, by Regions

9.1 Introduction

9.1.1 Americas

9.1.1.1 North America

9.1.1.2 South America

9.1.2 Europe

9.1.2.1 Germany

9.1.2.2 France

9.1.2.3 UK

9.1.2.4 Italy

9.1.2.5 Spain

9.1.2.6 Rest of Europe

9.1.3 Asia Pacific

9.1.3.1 Japan

9.1.3.2 China

9.1.3.3 India

9.1.3.4 Republic of Korea

9.1.3.5 Rest of Asia Pacific

9.1.4 Middle East & Africa

10 Company Landscape

10.1 Introduction

10.1.1 Mergers Acquisitions

10.1.2 Collaborations

10.1.3 Release/New Product Launches

10.1.4 Other (Expansion, Updates, Partnership)

11 Company Profile

11.1 Cipla Inc.

11.1.1 Company Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financials

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Dr. Reddy’s Laboratories Ltd.

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financials

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Johnson & Johnson

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financials

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.4 Merck & Co.

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financials

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.5 Ranbaxy Laboratories Ltd.

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financials

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 The Himalaya Drug Company

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Sun Pharmaceutical Industries Ltd

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

12 Others

13 Appendix



List of Tables

TABLE 1 GLOBAL ALOPECIA DRUGS MARKET, 2013-2022 (USD MILLION)

TABLE 2 GLOBAL ALOPECIA DRUGS MARKET, BY ALOPECIA TYPE, 2013-2022 (USD MILLION)

TABLE 3 GLOBAL ALOPECIA DRUGS MARKET, BY PRODUCT TYPE, 2013-2022 (USD MILLION)

TABLE 4 GLOBAL ALOPECIA DRUGS MARKET, BY GENDER, 2013-2022 (USD MILLION)

TABLE 5 GLOBAL ALOPECIA DRUGS MARKET, BY END-USERS, 2013-2022 (USD MILLION)

TABLE 6 GLOBAL ALOPECIA DRUGS MARKET, BY REGION, 2013-2022 (USD MILLION)

List of Figures



FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ALOPECIA DRUGS MARKET, BY ALOPECIA TYPE

FIGURE 4 GLOBAL ALOPECIA DRUGS MARKET, BY PRODUCT TYPE

FIGURE 5 GLOBAL ALOPECIA DRUGS MARKET, BY GENDER

FIGURE 6 GLOBAL ALOPECIA DRUGS MARKET, BY END-USERS

FIGURE 6 GLOBAL ALOPECIA DRUGS MARKET, BY REGION

FIGURE 7 GLOBAL ALOPECIA DRUGS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)